Author: Dr. Raymond A. Huml  Rare diseases affect millions worldwide, yet treatment options remain scarce. For families like ours who live with Facioscapulohumeral muscular dystrophy (FSHD) – the journey toward … Continue reading Understanding the FDA’s Orphan Drug Development Program: Why It Matters for FSHD and All Rare Disease Communities